More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) November 28, 2014

More than 2,100 Stryker hip lawsuits ( have now been filed in a New Jersey litigation that involves a pair of recalled metal implants, Bernstein Liebhard LLP reports.

A Case List updated on November 18th in Bergen County Superior Court reflects the filing of 2,160 claims over the Rejuvenate and ABG II modular-neck hip stems, which were voluntarily recalled on July 6, 2012 by their manufacturer, Stryker Orthopaedics. Plaintiffs in these lawsuits allege pain, swelling, a loss of mobility and symptoms associated with metallosis (metal ion poisoning) caused by the implants, which they claim to have been inadequately warned about prior to their being taken off the market. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

We are not surprised to see additional lawsuits continuing to be filed in New Jerseys metal hip litigation, as we continue to hear from clients who need to have their Rejuvenate and/or ABG II modular-neck hip stems revised, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to potential plaintiffs in Stryker recall lawsuits.

Stryker Hip Litigation

Before the New Jersey Stryker litigation issued its most recent update, the court announced a settlement that could resolve thousands of claims filed in state and federal courts over the recalled Rejuvenate and ABG II implants. According to documents released on November 3rd, the global settlement program provides for base awards of $ 300,000 per failed implant, which could vary depending on complications suffered during revision surgery, and other damages that may include future surgeries caused by the complications. Claimants who are medically unable to undergo revision surgery but need to do so will also be provided damage awards through the agreement, which will likely be received by the summer of 2015, the documents stipulate. All Stryker lawsuits in this litigation were filed after the 2012 recall, and similarly allege fretting and corrosion of the Rejuvenate and ABG II devices metal components.

In addition to Stryker recall claims filed in New Jersey, thousands of others have also been centralized in a federal multidistrict litigation established in the U.S. District Court, District of Minnesota. A Case List updated on November 17th shows that 2,179 cases have now been filed in the proceeding. Counsel involved in this proceeding are also signatories to the Stryker hip settlement agreement. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Rejuvenate and ABG II hip stem recipients may be eligible for compensation if they experienced complications related to the Stryker hip recall. To learn more, please visit Bernstein Liebhard LLPs website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016



This entry was posted in AI SEO and tagged , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply